← All trials
NCT05459298
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 6, 2022
- Primary completion
- Aug 1, 2024
- Completion date
- Dec 1, 2026
- First posted
- Jul 14, 2022
- Last posted
- Sep 10, 2022
- Enrollment
- 225
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of Texas at HoustonLead sponsor
- The Gerber FoundationCollaborator
- University of Texas at HoustonOverall official - principal investigator
- University of Texas at HoustonReponsible party - principal investigator
- National Center for Advancing Translational Science (NCATS)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.